Akili, Inc.
AKLI

$34.1 M
Marketcap
$0.43
Share price
Country
$0.00
Change (1 day)
$1.25
Year High
$0.19
Year Low

Akili, Inc., a digital medicine company, develops digital therapeutics for cognitive impairments. It provides EndeavorRx, a physician-prescribed video game-based treatment designed to directly target cognitive functioning. The company is based in Boston, Massachusetts.

marketcap

P/S ratio for Akili, Inc. (AKLI)

P/S ratio as of 2023: 22.70

According to Akili, Inc.'s latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 22.70. At the end of 2022 the company had a P/S ratio of 103.60.

P/S ratio history for Akili, Inc. from 2019 to 2023

P/S ratio at the end of each year

Year P/S ratio
2023 22.70
2022 103.60
2021 588.60
2020 199.84
2019 39.39